Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
Source: PRNewswire· August 17, 2026
SynaBot summary
Kyowa Kirin is partnering with Cognizant and Benchling to modernize its research and development processes. The collaboration aims to integrate data management, automate workflows, and leverage AI to speed up scientific discovery and drug development.
Key takeaways
- Kyowa Kirin enhances R&D with Cognizant and Benchling.
- Focus on integrated data and AI-driven automation.
- Goal is faster scientific discovery and drug development.
- Industry trend toward advanced AI in life sciences.
Why it matters
This initiative highlights how major pharmaceutical companies are adopting advanced AI and integrated platforms to streamline R&D. For AI users, it signals a trend toward more sophisticated, data-driven tools that can accelerate innovation cycles and improve research efficiency.
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire 
